ISREC SYMPOSIUM 2014 - "Metastatic Colonization - Micro Environments, Mechanisms, and Therapeutic Targeting"
Event details
| Date | 22.01.2014 › 25.01.2014 |
| Speaker |
Confirmed Speakers Julio A. Aguirre-Ghiso, The Mount Sinai Hospital, New York, USA Kari Alitalo, Biomedicum Helsinki, Finland Eduard Batlle, Institute for Research in Biomedicine, Barcelona, Spain Robert Benezra, Memorial Sloan-Kettering Institute, New York, USA Malcolm Brenner, Baylor College of Medicine, Houston, USA Richard Hynes, Howard Hughes Medical Institute, MIT, Cambridge, USA Tyler Jacks, David H. Koch Institute for Interative Cancer Research, MIT, Cambridge, USA Randall Johnson, University of Cambridge, United Kingdom Raghu Kalluri, Harvard Medical School, Boston, USA Yibin Kang, Princeton University, USA Christoph Klein, University of Regensburg, Germany Joan Massagué, Memorial Sloan-Kettering Cancer Center, New York, USA Angela Nieto, Instituto de Neurociencias CSIC-UMH, San Juan de Alicante, Spain Klaus Pantel, University Hospital Hamburg-Eppendorf, Germany Tatiana Petrova, CePO, CHUV, Lausanne, Switzerland Jeffrey Pollard, Albert Einstein College of Medicine, New York, USA Michael Stratton, Wellcome Trust Sanger Institute, Cambridge, UK Robert Weinberg, Whitehead Institute, MIT, Cambridge, USA Jing Yang, Univ. of California San Diego, USA |
| Location | |
| Category | Conferences - Seminars |
After the 2011 successful ISREC Symposium on various aspects of Cancer at large, we are pleased to announce our more focused CONFERENCE ON METASTASIS in early 2014 for which we invite you to participate. While the lethal impact of acquiring this hallmark capability during tumor progression has long been recognized, only in recent years have we begun to learn about the specific determinants that govern the process of tumor growth at secondary sites.
Thus, the focus of this conference will be on the heterotypic tumor micro-environment of metastatic lesions, as well as the prospect for and progress toward therapeutic targeting of metastatic lesions. Topics to be covered include the ontogeny of disseminated cancer cells that have landed in secondary sites in the course of establishing themselves as macroscopic tumors; reprogramming, recruiting, and organizing metastatic tumor micro-environment; mutationally and epigenetically evolving to successfully colonize; the immunobiology of metastatic lesions; novel therapies for metastases, including immune-based.
Sessions
• Dormancy, latency, and escape of disseminated tumor cells and micro-metastases
• Organ-specific factors governing metastatic outgrowth
• Parameters of macro-metastatic microenvironments
• Cancer cell intrinsic factors promoting metastatic colonization
• Immunobiology of metastatic lesions
• Frontiers of metastatic mechanisms and therapies
Thus, the focus of this conference will be on the heterotypic tumor micro-environment of metastatic lesions, as well as the prospect for and progress toward therapeutic targeting of metastatic lesions. Topics to be covered include the ontogeny of disseminated cancer cells that have landed in secondary sites in the course of establishing themselves as macroscopic tumors; reprogramming, recruiting, and organizing metastatic tumor micro-environment; mutationally and epigenetically evolving to successfully colonize; the immunobiology of metastatic lesions; novel therapies for metastases, including immune-based.
Sessions
• Dormancy, latency, and escape of disseminated tumor cells and micro-metastases
• Organ-specific factors governing metastatic outgrowth
• Parameters of macro-metastatic microenvironments
• Cancer cell intrinsic factors promoting metastatic colonization
• Immunobiology of metastatic lesions
• Frontiers of metastatic mechanisms and therapies
Practical information
- Informed public
- Registration required
Organizer
- Joerg Huelsken, Douglas Hanahan, Joan Massagué, Michele de Palma, Tatiana Petrova